{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-042811","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2022-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.322742+00:00","generated_at":"2026-06-26T09:31:23.941405+00:00","sec_items":["1.01","5.02","1.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tivic Health appoints Veronica Cai as CFO, Ryan Sabia as COO; CFO Benz resigns","bullets":["Briana Benz resigned as CFO effective April 1, 2022; 93,750 restricted shares repurchased for $375.","Veronica Cai appointed CFO with $325k base salary, 25% bonus target, and options for 117,880 shares at $1.61.","Ryan Sabia (COO since Dec 2021) enters employment agreement with $250k base salary and 25% bonus target.","Sanjay Ahuja joins as SVP Quality Assurance & Regulatory Affairs (press release).","Benz's departure not due to any disagreement with the company's operations or policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-042811","json":"https://secwatch.observer/filing/0001104659-22-042811.json","markdown":"https://secwatch.observer/filing/0001104659-22-042811.md","text":"https://secwatch.observer/filing/0001104659-22-042811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/tm2211661d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:31:23.941405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"06e6619528","claim":"Veronica Cai was appointed as Chief Financial Officer at Valion Bio, Inc..","evidence_excerpt":"On April 1, 2022, Veronica Cai was appointed as the Company’s new Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f037ae2c16","claim":"Briana Benz resigned as Chief Financial Officer at Valion Bio, Inc..","evidence_excerpt":"On April 1, 2022, Briana Benz resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc., a Delaware corporation (the “Company”), to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922042811/0001104659-22-042811-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}